Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × fezolinetant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Hot Flashes 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Docetaxel 263 Prednisone 207 enzalutamide 166 Leuprolide 162 Radiotherapy 153 Abiraterone Acetate 145 Magnetic Resonance Spectroscopy 139 bicalutamide 115 Goserelin 115 Androgen Antagonists 103 Radiosurgery 97 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 96 apalutamide 81 Specimen Handling 68 gallium 68 PSMA-11 67 abiraterone 66 darolutamide 56 Surveys and Questionnaires 53 Gonadotropin-Releasing Hormone 53 Biopsy 53 Radiation 51 Brachytherapy 50 cabazitaxel 47 Triptorelin Pamoate 47 Standard of Care 44 pembrolizumab 43 Zoledronic Acid 43 luprolide acetate gel depot 42 Radiotherapy, Intensity-Modulated 41 Carboplatin 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06972875 2026-02-05

FLASH

University of Vermont

Phase 2 Recruiting

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡